Novel 5-aryl-1,3-dihydro-indole-2-thiones
- 12 March 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (7) , 1317-1320
- https://doi.org/10.1016/s0960-894x(03)00129-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Potent nonsteroidal progesterone receptor agonists: Synthesis and SAR study of 6-aryl benzoxazinesBioorganic & Medicinal Chemistry Letters, 2002
- Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestoneThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- In vitro characterization of trimegestone: a new potent and selective progestinSteroids, 2000
- 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a Novel Class of Nonsteroidal Progesterone Receptor Agonists: Effect of A-Ring ModificationJournal of Medicinal Chemistry, 1999
- 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor AgonistsJournal of Medicinal Chemistry, 1998
- The nuclear receptor superfamily: The second decadeCell, 1995
- New contraceptives in the 1990sCurrent Opinion in Pediatrics, 1995
- The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.Proceedings of the National Academy of Sciences, 1993
- Background, Development and Properties of Progestagens, with Special Reference to Medroxyprogesterone Acetate (MPA)Acta Obstetricia et Gynecologica Scandinavica, 1981